| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 39 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sale+OE | 52,592 | $285.00 | $14,988,720.00 | -81.4% | -7.9% | +28.2% | |
| Jan 23, 2025 | Sharp Phillip A45 | Director | Sale+OE | 11,250 | $275.00 | $3,093,750.00 | -100% | -12.2% | +29.9% | |
| Dec 12, 2024 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 1,752 | $251.00 | $439,759.94 | -1.5% | -1.2% | +62.1% | |
| Nov 27, 2024 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 3,000 | $251.65 | $754,946.54 | -2.3% | -3.4% | +77.8% | |
| Nov 26, 2024 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 5,219 | $250.98 | $1,309,852.75 | -1.3% | -1.7% | +75.7% | |
| Nov 26, 2024 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 1,682 | $250.98 | $422,144.31 | -1.8% | -1.7% | +75.7% | |
| Nov 26, 2024 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 1,682 | $250.98 | $422,144.31 | -1.1% | -1.7% | +75.7% | |
| Nov 26, 2024 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,469 | $250.98 | $368,685.86 | -2.1% | -1.7% | +75.7% | |
| Oct 17, 2024 | Reitan Colleen F69 | Director | Buy | 36 | $287.85 | $10,362.68 | +112.5% | -15.4% | +62.3% | |
| Aug 20, 2024 | Greenstreet Yvonne49 | Chief Executive Officer | Sale+OE | 15,000 | $280.00 | $4,200,000.00 | -17.0% | -17.3% | +63.2% |